Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04733807
What this trial is testing

Antibodies Response to mRNA Vaccine Against Covid-19

Who this might be right for
Covid-19
University of Roma La Sapienza 600
Not applicableUnknownNCT04860908
What this trial is testing

COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO BETA CELL FUNCTION IN THE FETUS

Who this might be right for
Generation of Anti COVID-19 Antibodies in a Fetus, Whose Mother Was Exposed to COVID or Was Vaccinated During Pregnancy
Maaynei Hayesha Medical Center 100
Not applicableUnknownNCT04520880
What this trial is testing

Antibodies Responses to COVID-19 Infection in Hospitalized Patients

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV 2 Infection)Hospitalized PatientsLaboratory-confirmed SARS-CoV 2 Infection
Imam Abdulrahman Bin Faisal University 158
Large-scale testing (Phase 3)Ended earlyNCT04913675
What this trial is testing

Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19.

Who this might be right for
Covid19
Vir Biotechnology, Inc. 1,065
Not applicableStudy completedNCT06862531
What this trial is testing

A Single-center, Interventional Diagnostic Study With Minimal Risks and Constraints, Aimed at Longitudinally Evaluating Serum Antibody Levels in Patients With COVID-19 According to the Severity of Their Symptoms.

Who this might be right for
COVID-19
Bioaster 40
Not applicableStudy completedNCT04496141
What this trial is testing

Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19

Who this might be right for
Covid19
Hong Kong Sanatorium & Hospital 70
Large-scale testing (Phase 3)UnknownNCT04952805
What this trial is testing

Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.

Who this might be right for
Covid19
Toscana Life Sciences Sviluppo s.r.l. 800
Not applicableStudy completedNCT04354779
What this trial is testing

Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2SARS-CoV 2Coronavirus Infection+1 more
AUVA 3,301
Early research (Phase 1)Study completedNCT04464395
What this trial is testing

Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Corvus Pharmaceuticals, Inc. 30
Not applicableStudy completedNCT04393142
What this trial is testing

Serologic Testing of Household Contacts of Confirmed Cases of COVID-19

Who this might be right for
Coronavirus Infection
Hospital Universitario Dr. Jose E. Gonzalez 96
Not applicableStudy completedNCT04403386
What this trial is testing

Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19

Who this might be right for
COVID-19
National Institute of Environmental Health Sciences (NIEHS) 132
Testing effectiveness (Phase 2)Study completedNCT04521309
What this trial is testing

SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients

Who this might be right for
COVID-19
Dow University of Health Sciences 50
Early research (Phase 1)Study completedNCT04514302
What this trial is testing

Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19

Who this might be right for
COVID-19
TecSalud Investigación Clínica 32
Not applicableStudy completedNCT04590352
What this trial is testing

Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 Patients

Who this might be right for
SARS-CoV-2 Infection
Radboud University Medical Center 187
Not applicableUnknownNCT04402814
What this trial is testing

IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.

Who this might be right for
SARS-CoV 2
Fadi Haddad, M.D. 90
Testing effectiveness (Phase 2)Study completedNCT04780321
What this trial is testing

JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects

Who this might be right for
COVID-19
Shanghai Junshi Bioscience Co., Ltd. 62
Not applicableStudy completedNCT04526405
What this trial is testing

Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases

Who this might be right for
Thalassemia MajorCovid19
University of Milano Bicocca 63
Not applicableUnknownNCT04387929
What this trial is testing

Detection of Anti-COVID-19 Antibody Levels in an Hospital Population

Who this might be right for
COVID-19
Istituto Clinico Humanitas 6,000
Early research (Phase 1)UnknownNCT04685603
What this trial is testing

Dendritic Cell Vaccine to Prevent COVID-19

Who this might be right for
COVID-19
Indonesia-MoH 27
Not applicableWithdrawnNCT04418531
What this trial is testing

Convalescent Antibodies Infusion in COVID 19 Patients

Who this might be right for
Pneumonia, ViralCorona Virus Infection
Piero Luigi Ruggenenti
Next Page